The Latino Cancer Institute (TLCI) is a nationwide community and research network dedicated to solving the issues and burden of Latino cancer.
Scientists have discovered a rare inherited mutation in the CDK12 gene linked to aggressive prostate cancer, with all five identified carriers developing metastatic disease between ages 44 and 62. The finding could lead to expanded genetic testing, helping families uncover hidden cancer risks and potentially detect the disease while it is still treatable.
Scientists have discovered that a rare, potentially life-threatening inflammatory disorder is driven by malfunctioning immune cells, overturning three decades of scientific understanding. The breakthrough points to a promising new treatment using existing medications, with one severely affected infant already showing substantial improvement.
Scientists discovered that vitamin B12 largely reversed developmental abnormalities in worms carrying a genetic mutation linked to Verheij syndrome, a rare disorder that causes growth problems and developmental delays. Similar metabolic changes were identified in human patients, raising the possibility that this common vitamin could inspire new treatments for rare genetic diseases.
Scientists have discovered that vitamin C may help prevent potentially cancer-causing chemicals from forming in the stomach after eating foods containing nitrates and nitrites. A new mathematical model suggests that taking vitamin C after meals could reduce these harmful reactions, offering a possible new strategy for lowering cancer risk.
Scientists have uncovered a surprising genetic connection to spinal degeneration and found that an existing osteoporosis drug can prevent damaging mineral buildup in zebrafish spines. The discovery could pave the way for new treatments that slow or prevent a major cause of chronic back pain.
A surprising discovery from Rockefeller University suggests that a common amino acid could play a powerful role in protecting against cancer and viral infections. Scientists found that low arginine levels interfere with the immune system's ability to recognize dangerous cells, while increasing arginine intake reduced colon cancer tumors and improved viral infection outcomes in mice. Even more remarkably, giving mice arginine after they contracted influenza helped them recover.
Yale researchers have discovered that certain prescription drugs, healthy diets, and exercise can measurably slow biological aging, while popular anti-aging supplements appear largely ineffective. Their analysis of 51 studies could transform how scientists evaluate anti-aging treatments, although whether these biological changes actually extend life remains uncertain.
A new study reveals that viral infections may leave behind hidden damage to the immune system long after symptoms disappear. Researchers found that mice recovering from an acute infection experienced lasting changes to their spleens and weakened immune responses, potentially leaving them more vulnerable to future threats. Surprisingly, prior vaccination completely prevented these harmful changes in the mouse model.
A major study of nearly 1,900 older adults suggests that stopping statins after age 70 may be relatively safe in the short term for people who have never experienced a heart attack or stroke. However, a higher rate of serious cardiovascular events or death during longer follow-up raises questions about the risks of discontinuing these widely prescribed medications.
Colorectal cancer is making an alarming comeback in the United States after more than 20 years of declining rates, and the increase is no longer limited to younger adults. A major new study found rising rates across nearly every age group under 70, including older Americans who have historically benefited most from cancer screening.
An NIH study found that women with high levels of two common “forever chemicals” had up to 93% higher rates of an aggressive form of breast cancer. The discovery raises concerns about the potential health effects of persistent chemicals found in everyday products.
Scientists have uncovered a surprising way that fructose, a sugar commonly found in sweetened foods and drinks, may help aggressive ovarian cancer spread. Researchers discovered that cancer cells surviving chemotherapy release fructose that weakens the bonds holding neighboring tumor cells together, making it easier for cancer to spread. High dietary fructose levels and cholesterol-lowering statins also produced concerning effects in preclinical experiments.
Ancient manuscripts, including the 1,000-year-old York Gospels, have revealed traces of a deadly sheep virus whose history stretches back more than 3,700 years. Scientists discovered that the virus has remained remarkably unchanged for millennia, turning historic parchment into an unexpected record of ancient disease outbreaks.
A surprising new weapon against microbes linked to head and neck cancer could be as simple as chewing gum. Scientists developed a bioengineered gum that reduced HPV levels by up to 93% in oral samples from cancer patients and nearly eliminated two harmful bacterial species after a single dose of its extract. Even more promising, the treatment spared beneficial bacteria in the mouth.
Scientists have discovered that tumors release natural antioxidants to shut down the immune cells responsible for destroying cancer, exploiting a surprising weakness in the body's defenses. Blocking this mechanism in mice restored immune activity and improved immunotherapy responses, potentially opening a new path toward more effective cancer treatments.
Scientists have discovered that pantethine, a readily available vitamin B5 derivative, can calm overactive immune cells and may help fight psoriasis. The supplement prevented psoriasis in mice and showed promising results in a small human trial, revealing an unexpected connection between cholesterol and autoimmune inflammation.
A surprising new study from UCLA suggests that a naturally occurring molecule could help breast cancer survivors overcome the frustrating brain fog and exhaustion that can linger long after treatment ends. Researchers found that women taking an oxaloacetate supplement for eight weeks experienced substantial improvements in memory, concentration, mental clarity, and fatigue.
Scientists at UC San Francisco have developed a powerful new cancer therapy that remains inactive until it reaches the brain, where it switches on to attack deadly tumors. The engineered immune cells, called B-SYNC CAR-T cells, completely eliminated diffuse midline glioma (DMG), an aggressive childhood brain cancer that is almost always fatal within a year, in two mouse models.
MIT scientists have developed nanoparticles that reprogram immune cells directly inside the body to attack cancer and harmful immune cells, eliminating tumors and reversing liver damage in mouse experiments. The breakthrough could make powerful immune therapies dramatically simpler and less expensive while opening new possibilities for treating cancer and autoimmune diseases.
A surprising new study suggests that a stronger flu shot could offer older adults significantly greater protection against Alzheimer's disease. Researchers at UTHealth Houston analyzed nearly 200,000 adults ages 65 and older and found that those who received a high-dose influenza vaccine had a nearly 55% lower risk of developing Alzheimer's, compared with a 40% reduction previously associated with the standard-dose vaccine.
A study of nearly 5,800 adults found that heart scans measuring calcium buildup in the arteries led to the same observed rate of major cardiovascular events as traditional risk assessments, despite recommending statins to far fewer patients. Surprisingly, patients advised to take statins based on their scans were nearly three times as likely to stick with their medication, raising intriguing questions about how doctors should identify and treat heart disease risk.
Scientists have solved a decades-old mystery and uncovered a hidden immune system defense that protects healthy cells from the very inflammation meant to fight infections. The surprising discovery could lead to new approaches for treating cancer, inflammatory bowel disease, and other conditions involving excessive inflammation.
Scientists have discovered a compound that transforms a natural muscle-repair protein into a more powerful version dubbed "Super HGF," more than doubling its ability to bind to a key receptor while protecting it from age-related chemical damage. The breakthrough, supported by early mouse experiments, could eventually help combat muscle loss and preserve strength as people age.
Scientists have developed a promising new cancer-fighting strategy that uses carbon monoxide naturally produced by tumor cells to manufacture powerful drugs inside the cancer cells themselves. Early laboratory experiments suggest the technique could selectively attack cancer while sparing healthy cells, potentially paving the way for safer chemotherapy alternatives.
Scientists have discovered that a drug originally developed for spinal cord injuries can tackle several key features of Alzheimer’s disease, including DNA damage and inflammation. Already tested for initial safety in humans, the experimental treatment could offer a faster path toward therapies that target the disease at its roots.
Scientists at the University of Virginia have developed a promising new strategy to fight glioblastoma, one of the deadliest and most difficult-to-treat forms of brain cancer. Their experimental approach combines focused ultrasound, tiny nanoparticles, and genetic molecules called microRNAs to attack multiple cancer-driving genes simultaneously.
Scientists at Johns Hopkins have uncovered a crucial missing link between a common gut bacterium and colorectal cancer, solving a mystery that has puzzled researchers for nearly two decades. The bacterium, Bacteroides fragilis, produces a toxin that damages the colon’s protective lining, triggers chronic inflammation, and promotes tumor formation.
Scientists at Johns Hopkins University have uncovered a surprising process that helps humans develop sharp vision before birth, challenging decades of assumptions about how the eye forms. Using miniature human retinas grown in the lab, researchers discovered that a vitamin A derivative and thyroid hormones work together to shape the foveola, the tiny region at the center of the retina responsible for our sharpest vision.
Scientists have uncovered hidden aggressive cancer cells in children whose tumors were previously considered lower risk, revealing why some cases of rhabdomyosarcoma become unexpectedly deadly. The discovery could help doctors identify dangerous tumors earlier and develop personalized treatments that improve survival while reducing unnecessary chemotherapy.
A surprising discovery reveals that widely used anti-inflammatory drugs may unintentionally help dangerous viruses spread through the body. Scientists found that JAK inhibitors, prescribed for rheumatoid arthritis and other inflammatory diseases, can weaken a crucial immune defense against influenza, COVID-19, and other infections. By suppressing genes that normally fight viruses, these medications may leave patients more vulnerable to infection.
A powerful new AI system could help doctors detect pancreatic cancer years before it becomes visible on conventional scans. The technology, called REDMOD, identified hidden warning signs an average of 475 days before diagnosis and was nearly twice as sensitive as experienced radiologists. By spotting cancer-related changes at their earliest stages, it could dramatically improve the chances of successful treatment for one of the deadliest forms of cancer.
Scientists have discovered how pancreatic cancer cells continually reshape their genetic makeup to become more aggressive, spread, and evade treatment. In laboratory experiments, blocking a key gene reversed some of these dangerous changes, revealing a potential new way to fight the deadly disease.
Scientists discovered that the thick, sticky fluid surrounding glioblastoma tumors can make brain cancer cells smaller, more flexible, and better at invading surrounding tissue. Even more troubling, some of these changes persist after the cells leave the thick fluid, revealing a previously overlooked mechanism that could help this deadly cancer spread.
Researchers have uncovered a hidden immune defense capable of attacking small cell lung cancer, an extremely aggressive disease that often escapes conventional treatments. The specialized immune cells can recognize and destroy cancer cells even when tumors have disguised themselves from the immune system.
Scientists have captured virus-like particles assembling themselves step by step, revealing how a surprisingly simple process of trial and error produces complex structures with remarkable precision. The discovery uncovers a crucial molecular turning point that speeds up assembly and could lead to new ways to disrupt viruses and develop vaccines.
Scientists have uncovered a surprising reason why statins, the widely prescribed cholesterol-lowering drugs that help prevent heart attacks and strokes, can sometimes cause muscle pain, weakness, and even severe muscle damage. Using advanced imaging technology, researchers discovered that statins can attach to a crucial protein in muscle cells and force open a channel that normally controls calcium flow. This causes calcium to leak continuously, potentially damaging muscle tissue.
As a nonprofit organization, we rely on philanthropy and grants in our mission to support other agencies. Your funding allows us to continue the development of new programs and tools we can share with those making a difference in the lives of Latino cancer patients, survivors, and their caregivers.